Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study

2024-1-1

HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM

2024-1-1

Diabetes and gout: another role for SGLT2 inhibitors?

2024-1-1

Glycogen storage disease type III: a mixed-methods study to assess the burden of disease

2024-1-1

Semaglutide in the spotlight: weighing benefits against rising concerns

2024-1-1

The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review

2024-1-1

Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications

2024-1-1

MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight

2024-1-1

Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves’ disease: case report

2024-1-1

Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review

2024-1-1

Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol

2024-1-1

Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor

2024-1-1

Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes

2024-1-1

Remote myocardial zone characteristics in type 2 diabetes patients with prior myocardial infarction and comparisons with diabetes patients with no prior infarction

2024-1-1

Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review

2024-1-1

Phenotypic characterization of nonautoimmune diabetes in adult Ugandans with low body mass index

2024-1-1

Epidemiology of gout – Global burden of disease research from 1990 to 2019 and future trend predictions

2024-1-1

Gut microbiota in MAFLD: therapeutic and diagnostic implications

2024-1-1

Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis

2024-1-1

Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system

2024-1-1

Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions

2024-1-1

ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients

2024-1-1

Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications

2023-1-1

Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges

2023-1-1

A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke

2023-1-1

Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults

2023-1-1

Immune checkpoint inhibitors: friend or foe for osteoporosis

2023-1-1

Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide <i>versus</i> placebo on intestinal barrier function in type 2 diabetes mellitus

2023-1-1

Patient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes: a structured qualitative assessment

2023-1-1

Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study

2023-1-1

Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populations

2023-1-1

Fractures and dislocations of the foot and ankle in people with diabetes: a literature review

2023-1-1

Implications of gender-affirming endocrine care for sports participation

2023-1-1

Non-pharmacological management options for MAFLD: a practical guide

2023-1-1

Pheochromocytoma: a changing perspective and current concepts

2023-1-1

Association of hyponatremia with bone mineral density and fractures: a narrative review

2023-1-1

Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)

2023-1-1

Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes

2023-1-1

MAFLD: a multisystem disease

2023-1-1

Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans

2023-1-1

Should we undertake surveillance for HCC in patients with MAFLD?

2023-1-1

The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis

2023-1-1

Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective

2023-1-1

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease

2023-1-1

Controversies in the management of active Charcot neuroarthropathy

2023-1-1

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone

2023-1-1

Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers

2023-1-1

Is there a causal relationship between hypothyroidism and hyponatremia?

2023-1-1

Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus

2023-1-1

Exploring the mechanism of metformin action in Alzheimer’s disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation

2023-1-1